Aptevo

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. 

CEO
Marvin L. White
CEOMarvin L. White
Employees
54
Employees54
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2016
Founded2016
Employees
54
Employees54

APVO Key Statistics

Market cap
15.63M
Market cap15.63M
Price-Earnings ratio
2.39
Price-Earnings ratio2.39
Dividend yield
Dividend yield
Average volume
48.79K
Average volume48.79K
High today
$3.17
High today$3.17
Low today
$3.03
Low today$3.03
Open price
$3.08
Open price$3.08
Volume
41.63K
Volume41.63K
52 Week high
$22.08
52 Week high$22.08
52 Week low
$3.03
52 Week low$3.03

APVO Earnings

-$1.84
-$0.66
$0.51
$1.69
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.